Drug profile · INN
phenoxybenzamine
AMDIPHARM MERCURY (AUSTRALIA) PTY LIMITED
phenoxybenzamine (AMDIPHARM MERCURY (AUSTRALIA) PTY LIMITED) is a adrenergic receptor alpha antagonist. Associated with Amdipharm Mercury (Australia) Pty Limited.
Drug details — phenoxybenzamine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
phenoxybenzamine (AMDIPHARM MERCURY (AUSTRALIA) PTY LIMITED) is a adrenergic receptor alpha antagonist. Associated with Amdipharm Mercury (Australia) Pty Limited.
Key facts
Mechanism of action
Adrenergic receptor alpha antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is phenoxybenzamine?
phenoxybenzamine (AMDIPHARM MERCURY (AUSTRALIA) PTY LIMITED) is a adrenergic receptor alpha antagonist. Associated with Amdipharm Mercury (Australia) Pty Limited.
What is the brand name for phenoxybenzamine?
AMDIPHARM MERCURY (AUSTRALIA) PTY LIMITED is a marketed brand name for phenoxybenzamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.